- Home
- LGCB vs ONCO Comparison
LGCB vs ONCO Comparison
Compare LGCB & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- ONCO
- Stock Information
- Founded
- LGCB 2011
- ONCO 2018
- Country
- LGCB Japan
- ONCO United States
- Employees
- LGCB N/A
- ONCO N/A
- Industry
- LGCB
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- LGCB
- ONCO Health Care
- Exchange
- LGCB Nasdaq
- ONCO Nasdaq
- Market Cap
- LGCB 16.7M
- ONCO 1.8M
- IPO Year
- LGCB 2023
- ONCO 2022
- Fundamental
- Price
- LGCB $2.52
- ONCO $3.16
- Analyst Decision
- LGCB
- ONCO
- Analyst Count
- LGCB 0
- ONCO 0
- Target Price
- LGCB N/A
- ONCO N/A
- AVG Volume (30 Days)
- LGCB 5.6K
- ONCO 45.9K
- Earning Date
- LGCB 07-03-2025
- ONCO 08-14-2025
- Dividend Yield
- LGCB N/A
- ONCO N/A
- EPS Growth
- LGCB N/A
- ONCO N/A
- EPS
- LGCB N/A
- ONCO N/A
- Revenue
- LGCB $8,993,265.00
- ONCO $1,326,959.00
- Revenue This Year
- LGCB N/A
- ONCO N/A
- Revenue Next Year
- LGCB N/A
- ONCO N/A
- P/E Ratio
- LGCB N/A
- ONCO N/A
- Revenue Growth
- LGCB 5.80
- ONCO N/A
- 52 Week Low
- LGCB $1.22
- ONCO $2.61
- 52 Week High
- LGCB $13.70
- ONCO $552.50
- Technical
- Relative Strength Index (RSI)
- LGCB 60.70
- ONCO 52.40
- Support Level
- LGCB $2.21
- ONCO $3.00
- Resistance Level
- LGCB $2.26
- ONCO $3.32
- Average True Range (ATR)
- LGCB 0.09
- ONCO 0.16
- MACD
- LGCB 0.05
- ONCO 0.08
- Stochastic Oscillator
- LGCB 65.05
- ONCO 75.74
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.